Metabolic Differences Between Subtypes of Polycystic Ovary Syndrome
NCT06342180 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 300
Last updated 2024-04-02
Summary
We aimed to investigate serum uric acid levels in patients with different phenotype of policystic ovary syndrome and to compare healthy controls.
Conditions
- Uric Acid Concentration, Serum, Quantitative Trait Locus 7
- Polycystic Ovary Syndrome
Interventions
- DIAGNOSTIC_TEST
-
Serum uric acid level
An amount of 2-3 ml of blood sample will be collected from the patients after 8-12 hours of fasting and will be kept frozen at -70 degrees to calculate the serum UA level.
Sponsors & Collaborators
-
Uşak University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 35 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-01-01
- Primary Completion
- 2022-09-01
- Completion
- 2023-07-20
Countries
- Turkey (Türkiye)
Study Locations
More Related Trials
-
Aerobic Capacity and Physical Fitness Level of Adolescents With PCOS
NCT05246306 ·Status: COMPLETED
-
Novel Subtypes of Polycystic Ovary Syndrome
NCT06124391 ·Status: RECRUITING
-
Ultrasonographic Evaluation of Ovarian Stromal Vascularity in Women With Polycystic Ovary Syndrome (PCOS)
NCT05418595 ·Status: COMPLETED
-
Comparison of Serum C Type Natriuretic Peptide Levels Between Polycystic Ovary Syndrome Patients and Healthy Women
NCT04006171 ·Status: COMPLETED ·Phase: NA
-
The Effect of Polycystic Ovary Syndrome on Pelvic Floor Structure and Function
NCT04398186 ·Status: COMPLETED
-
Analysis of Clinical Characteristics and Study of Diagnostic Markers in Patients with Polycystic Ovary Syndrome
NCT05063383 ·Status: RECRUITING
-
Nutrition Intervention for Women With Polycystic Ovary Syndrome
NCT07298603 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Serum Endocan Levels in Polycystic Ovary Syndrome
NCT03019679 ·Status: COMPLETED
-
Comparison of Bone Morphogenetic Protein-4 (BMP-4) and 7 Levels Between Control and Polycystic Ovarian Syndrome (PCOS) Patients.
NCT01162447 ·Status: UNKNOWN
-
Ovarian Reserve and Matrix Metalloproteinases
NCT05443282 ·Status: COMPLETED
-
The Effect of Polycystic Ovary Syndrome Phenotypes on Quality of Life and Sexual Function
NCT06428786 ·Status: COMPLETED
-
Serum Anti-Mullerian Hormone (AMH) Levels in Overweight and Obese Adolescent Girls With Polycystic Ovaries
NCT01856894 ·Status: COMPLETED
-
Evaluation of Endocrine and Metabolic Parameters in the New Diagnostic Phenotypes of Polycystic Ovary Syndrome
NCT00784615 ·Status: UNKNOWN
-
Comparison of Docosahexaenoic (DHA) Values in Patients With Polycystic Ovary Syndrome (PCOS)
NCT05597111 ·Status: UNKNOWN
-
Cardiovascular Risks and Urinary Albumin Excretion(UAE) in Polycystic Ovarian Syndrome (PCO)
NCT02569164 ·Status: UNKNOWN
-
Polycystic Ovary Syndrome and Urinary Tract Stones: a BMI-Adjusted Analysis in Iraqi Women
NCT06729359 ·Status: COMPLETED
-
Serum Metabolomics Study of Polycystic Ovary Syndrome
NCT03618342 ·Status: UNKNOWN
-
Women With Polycystic Ovary Syndrome Have Increased Plasma Chitotriosidase Activity
NCT01382576 ·Status: COMPLETED
-
Endocrine and Menstrual Disturbances in Women With Polycystic Ovary Syndrome (PCOS)
NCT03652987 ·Status: SUSPENDED
-
Ocular Findings of Polycystic Ovary Syndrome
NCT03896841 ·Status: COMPLETED
-
Oxidative Stress in Polycystic Ovary Syndrome
NCT06826625 ·Status: COMPLETED
-
Molecular Basis of PCOS in Oocytes and Surrounding Cells
NCT04493788 ·Status: UNKNOWN
-
The Potential Biochemical Diagnosis Criteria and Therapeutic Effect Indexes: Sex Hormone Binding Globulin Levels and Free Androgen Index in Blood of Patients With Polycystic Ovary Syndrome
NCT01784380 ·Status: COMPLETED
-
Breast Ultrasonography and Polycystic Ovary Syndrome
NCT04231786 ·Status: COMPLETED
-
LH/FSH, Testosterone, Prolactin, and Ferritin in PCOS Patients in Jordan
NCT07112768 ·Status: COMPLETED